"Unrelated Donors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Providers of tissues for transplant to non-related individuals.
Descriptor ID |
D061349
|
MeSH Number(s) |
M01.898.828
|
Concept/Terms |
Unrelated Donors- Unrelated Donors
- Donor, Unrelated
- Unrelated Donor
- Donors, Unrelated
|
Below are MeSH descriptors whose meaning is more general than "Unrelated Donors".
Below are MeSH descriptors whose meaning is more specific than "Unrelated Donors".
This graph shows the total number of publications written about "Unrelated Donors" by people in this website by year, and whether "Unrelated Donors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 3 | 1 | 4 |
2012 | 3 | 4 | 7 |
2013 | 4 | 2 | 6 |
2014 | 5 | 3 | 8 |
2015 | 3 | 5 | 8 |
2016 | 4 | 5 | 9 |
2017 | 3 | 2 | 5 |
2018 | 7 | 6 | 13 |
2019 | 3 | 0 | 3 |
2020 | 3 | 11 | 14 |
2021 | 1 | 6 | 7 |
2022 | 0 | 5 | 5 |
2023 | 0 | 8 | 8 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Unrelated Donors" by people in Profiles.
-
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke. Stem Cells Transl Med. 2024 Feb 14; 13(2):125-136.
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 Apr; 99(4):785-788.
-
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age. Am J Hematol. 2024 Jan; 99(1):38-47.
-
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis. Blood Adv. 2023 08 08; 7(15):3993-4002.
-
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 Oct; 29(10):611-618.
-
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023 Jun 22; 388(25):2338-2348.
-
Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type. Blood Adv. 2023 04 25; 7(8):1594-1603.
-
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia. Transplant Cell Ther. 2023 06; 29(6):377.e1-377.e7.
-
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS. Am J Hematol. 2023 05; 98(5):712-719.
-
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation. Cancer. 2023 04 15; 129(8):1205-1216.